vindesine has been researched along with Local Neoplasm Recurrence in 49 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (30.61) | 18.7374 |
1990's | 22 (44.90) | 18.2507 |
2000's | 5 (10.20) | 29.6817 |
2010's | 6 (12.24) | 24.3611 |
2020's | 1 (2.04) | 2.80 |
Authors | Studies |
---|---|
Jin, M; Wang, Z; Zhai, Z; Zhang, K | 1 |
Chen, L; Du, J; Li, M; Li, Y; Mi, R; Wei, X; Yin, Q | 1 |
Li, WF; Shao, XH; Xu, YS; Zhang, XQ | 1 |
Autran, D; Barrie, M; Bequet, C; Chinot, O; Daros, M; Dehais, C; Delattre, JY; Duran, A; Matta, M; Petrirena, G; Reyes-Botero, G; Tabouret, E | 1 |
Chen, YL; Ma, XH; Qiu, ZY; Ren, CA; Wang, YF; Xu, WJ | 1 |
Andersen, PK; Cortese, G; Nielsen, D; Nielsen, G; Ryberg, M; Skovsgaard, T | 1 |
Aoki, T; Igarashi, Y; Kobayashi, K; Komori, T; Matsumoto, T; Nishioka, K; Takachi, K; Tanida, T; Tanizaki, K; Tsukao, Y; Uemura, Y | 1 |
Abrous-Anane, S; Bollet, MA; Campana, F; Daveau, C; Dendale, R; Fourquet, A; Gautier, C; Kirova, YM; Pierga, JY; Reyal, F; Savignoni, A | 1 |
Batchelor, TT; Egerer, G; Engert, A; Herrlinger, U; Kowoll, A; Lamprecht, M; Linnebank, M; Patrij, K; Pels, H; Reiser, M; Schackert, G; Schlegel, U; Schmidt-Wolf, IG; Vogt-Schaden, M; Wätzel, L | 1 |
Acito, L; Bacchi, M; Beretta, M; Carlini, P; Cocconi, G; Di Sarra, S; Foladore, S; Gebbia, V; Maiello, E; Marchi, M; Passalacqua, R | 1 |
Coens, C; Kobierska, A; Lhomme, C; Namer, M; van der Burg, ME; van Luijk, IF; Vermorken, JB; Zanetta, G; Zola, P | 1 |
Krischke, W; Niederle, N; Schmidt, CG; Schütte, J; Seeber, S | 1 |
Scherpe, A; Schröder, M; Stennert, E; von Heyden, HW | 1 |
Rørth, M; Sandberg Nielsen, E; Schultz, HP; Svennekjaer, IL; von der Maase, H | 1 |
Niederle, N; Schmidt, CG; Schütte, J; Seeber, S | 1 |
Brunet, R; Bui, BN; Chauvergne, J; Durand, M; Hoerni, B; Mauriac, L | 1 |
Dölken, G; Fuchs, R; Gerhartz, H; Hagen-Aukamp, U; Hiller, E; Löffler, M; Petsch, S; Pflüger, KH; Pfreundschuh, M; Rühl, U | 2 |
Kalifa, C; Lemerle, J; Raquin, M; Rodary, C; Tabone, MD; Valteau-Couanet, D | 1 |
Cairncross, JG | 1 |
Berger, C; Body, G; Bougnoux, P; Calais, G; Chapet, S; Descamps, P; Lansac, J; Le Floch, O; Reynaud-Bougnoux, A | 1 |
Arriagada, R; Douillard, JY; Lacombe-Terrier, MJ; Laplanche, A; Le Chevalier, T; Martin, M; Quoix, E; Ruffie, P; Tarayre, M | 1 |
Miyazawa, N; Mori, T; Ohta, M; Sawamura, K; Shimoyama, M; Suemasu, K; Terashima, M; Tomita, M; Tsuchiya, R; Watanabe, Y | 1 |
Bauer, J; De Grandi, P; Delaloye, JF; Leyvraz, S; Outcha Adjahoto, E | 1 |
Arriagada, R; Baldeyrou, P; Bretel, JJ; Cosset, BP; Grunenwald, D; Le Chevalier, T; Le Péchoux, C; Ruffié, P | 1 |
Armand, JP; Bernal, ET; Cvitkovic, E; Domenge, C; Guillot, T; Janot, F; Sigal, R; Wibault, P | 1 |
Arriagada, R; Baldeyrou, P; Bretel, JJ; Grunenwald, D; Le Chevalier, T; Le Péchoux, C; Pellae-Cosset, B; Ruffié, P | 1 |
Aoki, K; Ikeda, K; Ishida, K; Iwaya, T; Kimura, Y; Koeda, K; Ogasawara, S; Ohtsuka, K; Saito, K; Sato, N | 1 |
Heimans, JJ; Hoekstra, OS; Postma, TJ; Roesdi, MF; van Groeningen, CJ; Wolbers, JG | 1 |
DeAngelis, LM; Olson, JD; Riedel, E | 1 |
Bastion, Y; Blanc, M; Bryon, PA; Coiffier, B; Dumontet, C; Felman, P; Ffrench, M; Peaud, PY | 1 |
Gianoutsos, P; Grygiel, J; Lee, JH; McCaughan, BC; McNeil, E; Raghavan, D; Stockler, M | 1 |
Bonichon, F; Chauvergne, J; Dilhuydy, JM; Durand, M; Mauriac, L | 1 |
Aso, H; Hara, N; Ichinose, Y; Kuda, T; Motohiro, A; Ohta, M | 1 |
Armand, JP; Belehradek, M; Cvitkovic, E; De Vathaire, F; Domenge, C; Recondo, G; Richard, JM; Tellez-Bernal, E; Wibault, P | 1 |
Campana, F; Fourquet, A; Palangié, T; Pouillart, P; Vilcoq, JR | 1 |
Avril, A; Dilhuydy, JM; Durand, M; Mauriac, L | 1 |
De Boben, M; Diedrich, H; Freund, M; Ganser, A; Heil, G; Henke, M; Heyll, A; Hiddemann, W; Knauf, U; Koch, P | 1 |
Kobayashi, M; Kuwahara, A; Miyahara, M; Saito, T; Shigemitsu, Y; Shimoda, K; Zeze, K | 1 |
Errington, RD; Green, JA; Warenius, HM; Watkin, SW | 1 |
Callís, M; Domingo Albós, A; Fernández-Sevilla, A; Juliá, A; Petit, J; Puig, J; Vilá, J; Zuazu, J | 1 |
Arriagada, R; Baldeyrou, P; Le Chevalier, T; Ruffié, P; Thomas, F | 1 |
Alavi, JB; Kirkwood, R; Marsh, JC; Schoenfeld, D; Skeel, RT; Tsung, L | 1 |
Kawahara, T; Nakayama, H; Takatsuka, Y | 1 |
Höfeler, H; Höffken, K; Kath, R; Müller, M; Niederle, N; Schmidt, CG; Schoetensack, B; Wandl, U | 1 |
Hammond, D; Krailo, MD; Krivit, W; Sather, H | 1 |
Akiba, T; Eguchi, K; Fujiwara, Y; Miyamoto, K; Saijo, N; Sakurai, M; Sasaki, Y; Shinkai, T; Tamura, T; Uei, Y | 1 |
Rhomberg, WU | 1 |
3 review(s) available for vindesine and Local Neoplasm Recurrence
Article | Year |
---|---|
Aggressive oligodendroglioma: a chemosensitive tumor.
Topics: Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cyclophosphamide; Glioma; Humans; Lomustine; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Salvage Therapy; Vincristine; Vindesine | 1994 |
[Treatment of patients with recurrent esophageal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Prognosis; Survival Rate; Vindesine | 1998 |
[Concomitant association of radiotherapy and chemotherapy in inflammatory breast cancer. Initial results of phase II trial].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Inflammation; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy Dosage; Survival Rate; Vindesine | 1991 |
18 trial(s) available for vindesine and Local Neoplasm Recurrence
Article | Year |
---|---|
Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifen: a prospective randomized study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Skin Neoplasms; Survival Rate; Tamoxifen; Treatment Outcome; Vindesine | 2003 |
Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Female; Humans; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms; Vindesine | 2007 |
[Indications for cytostatic therapy of recurrent cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Female; Germany, West; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Vinblastine; Vindesine | 1984 |
Non-seminomatous testicular germ cell tumours. Preliminary analysis of ongoing trials in the DATECA Study.
Topics: Actuarial Analysis; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Clinical Trials as Topic; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Random Allocation; Testicular Neoplasms; Vinblastine; Vindesine | 1984 |
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Prognosis; Prospective Studies; Remission Induction; Risk Factors; Salvage Therapy; Survival Analysis; Survival Rate; Treatment Failure; Vinblastine; Vincristine; Vindesine | 1994 |
Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Humans; Life Tables; Lomustine; Lung Neoplasms; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome; Vindesine | 1994 |
A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma. Japanese Esophageal Oncology Group.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Radiotherapy Dosage; Survival Rate; Vindesine | 1993 |
Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer. Results of a randomized prospective study. The Japan Clinical Oncology Group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Survival Analysis; Vindesine | 1993 |
Concurrent cisplatin-vindesine and hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Compliance; Radiotherapy Dosage; Survival Rate; Time Factors; Vindesine | 1996 |
[Optimization of combined radiotherapy and chemotherapy in treatment of non-small cell lung carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Survival Rate; Treatment Outcome; Vinblastine; Vindesine | 1997 |
[Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine; Vindesine | 1992 |
Randomized trial of adjuvant chemotherapy for operable breast cancer comparing i.v. CMF to an epirubicin-containing regimen [see comment].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Injections, Intravenous; Methotrexate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Thiotepa; Vincristine; Vindesine | 1992 |
Postoperative adjuvant chemotherapy in non-small cell lung cancer: prognostic value of DNA ploidy and post-recurrent survival.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; DNA, Neoplasm; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Neoplasm Staging; Peplomycin; Ploidies; Prognosis; Vindesine | 1991 |
[Concomitant association of radiotherapy and chemotherapy in inflammatory breast cancer. Initial results of phase II trial].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Inflammation; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy Dosage; Survival Rate; Vindesine | 1991 |
Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Protocols; Epirubicin; Female; Humans; Lymph Node Excision; Mastectomy; Methotrexate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Thiotepa; Vincristine; Vindesine | 1991 |
Treatment of relapsed acute lymphocytic leukemia in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Germany, West; Humans; Ifosfamide; Leucovorin; Life Tables; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spinal Cord Neoplasms; Teniposide; Testicular Neoplasms; Vindesine | 1990 |
Phase II trial of spirogermanium and vindesine in malignant glioma.
Topics: Adult; Aged; Cerebellar Neoplasms; Drug Administration Schedule; Drug Evaluation; Glioma; Humans; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Random Allocation; Spiro Compounds; Vindesine | 1989 |
Phase II study of vindesine in the treatment of pediatric patients with solid tumors: a report from the Childrens Cancer Study Group.
Topics: Child; Clinical Trials as Topic; Drug Evaluation; Humans; Neoplasm Recurrence, Local; Neoplasms; Vindesine | 1986 |
29 other study(ies) available for vindesine and Local Neoplasm Recurrence
Article | Year |
---|---|
Peripheral blood CD45RO+T cells is a predictor of the effectiveness of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Separation; Chemoradiotherapy, Adjuvant; Colonoscopy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Flow Cytometry; Follow-Up Studies; Humans; Leukocyte Common Antigens; Lymphocyte Count; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Oxaliplatin; Prednisone; Preoperative Period; Proctectomy; Prognosis; Radiotherapy, Intensity-Modulated; Rectal Neoplasms; Rectum; Retrospective Studies; Survival Rate; T-Lymphocyte Subsets; Vindesine | 2021 |
Treatment with cyclophosphamide, vindesine, cytarabine, dexamethasone and bleomycin in patients with relapsed/refractory diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies; Treatment Outcome; Vindesine; Young Adult | 2014 |
Evidence based analysis of Cisplatin for treating patients with cutaneous squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Humans; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Salvage Therapy; Skin Neoplasms; Survival Rate; Vindesine | 2014 |
Relationships Between Dose Intensity, Toxicity, and Outcome in Patients with Oligodendroglial Tumors Treated with the PCV Regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Retrospective Studies; Treatment Outcome; Vindesine | 2015 |
[Effect of BD Regimen Combined with Cyclophosphamide and Pirarubicin in Treatment of Relapse/Refractory Multiple Myeloma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Lomustine; Multiple Myeloma; Neoplasm Recurrence, Local; Vindesine | 2016 |
New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
Topics: Adult; Age Factors; Aged; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Denmark; Disease Susceptibility; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Heart; Heart Failure; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Severity of Illness Index; Tamoxifen; Vindesine | 2008 |
[A complete response (CR) case of multiple lung metastases after radical lobectomy for non-small-cell-lung cancer obtained by cisplatin+vindesine].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Tomography, X-Ray Computed; Vindesine | 2008 |
Management of inflammatory breast cancer after neoadjuvant chemotherapy.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Inflammatory Breast Neoplasms; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Survival Rate; Vinblastine; Vindesine; Vinorelbine | 2011 |
Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Disease-Free Survival; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine; Vindesine | 2011 |
Vindesine/cisplatin chemotherapy in relapsed or primarily resistant small-cell carcinoma of the lung.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Drug Resistance; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Vinblastine; Vindesine | 1984 |
Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Evaluation; Humans; Immune Tolerance; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Vinblastine; Vindesine | 1984 |
[Chemotherapy associating mitomycin C, thiotepa and vindesine in advanced breast cancers. Study of 100 cases (author's transl)].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Thiotepa; Vinblastine; Vindesine | 1981 |
Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Extremities; Female; Follow-Up Studies; Humans; Ifosfamide; Leucovorin; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Vindesine | 1994 |
Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cobalt Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy, Modified Radical; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Survival Rate; Tamoxifen; Treatment Failure; Vindesine | 1994 |
Salvage chemotherapy with mitomycin, vindesine, and cisplatin (MiViP) in recurrent carcinoma of the cervix.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma; Cisplatin; Disease Progression; Female; Humans; Middle Aged; Mitomycins; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Survival Rate; Uterine Cervical Neoplasms; Vindesine | 1996 |
Neoadjuvant chemotherapy with cisplatin-vindesine-5-fluorouracil and folinic acid for locally advanced head and neck carcinoma.
Topics: Adult; Aged; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Survival Rate; Vindesine | 1996 |
Thallium-201 SPECT as response parameter for PCV chemotherapy in recurrent glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Cyclophosphamide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vindesine | 1998 |
Long-term outcome of low-grade oligodendroglioma and mixed glioma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Cyclophosphamide; Disease-Free Survival; Female; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Oligodendroglioma; Postoperative Complications; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Treatment Outcome; Vindesine | 2000 |
[Prognostic factors, late relapse and outcome of patients with aggressive malignant lymphoma: long term results of LNH-80 protocol].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Treatment Outcome; Vindesine | 1992 |
Combination chemotherapy with cisplatin, vindesine and mitomycin-C for advanced, inoperable non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Neoplasm Recurrence, Local; Palliative Care; Survival Rate; Treatment Outcome; Vindesine | 1992 |
Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Survival Analysis; Time Factors; Vindesine | 1991 |
[Combined chemoradio (CVPR) therapy in the treatment of inoperable and recurrent esophageal cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Peplomycin; Radiotherapy Dosage; Vindesine | 1988 |
Sequential combination chemotherapy and radiotherapy in locally advanced non-small cell carcinoma of the bronchus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Feasibility Studies; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Survival Analysis; Vindesine | 1989 |
[Vindesine, CCNU, high-dosage ara-C, and prednisolone (VINAP regimen) in the treatment of relapsing or refractory non-Hodgkin's lymphomas].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Drug Resistance; Female; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Remission Induction; Vindesine | 1989 |
Should chemotherapy response be evaluated separately in sequential chemotherapy-radiotherapy schedules in locally advanced nonsmall-cell lung carcinoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Time Factors; Vindesine | 1988 |
[Combination chemotherapy using low-dose epirubicin and vindesine in patients with metastatic breast cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Tamoxifen; Tegafur; Uracil; Vindesine | 1988 |
[Therapy of primary resistant or recurrent small cell bronchial carcinoma with vindesine and ifosfamide].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Administration Schedule; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Neoplasm Recurrence, Local; Vindesine | 1986 |
A case of adenocarcinoma of the lung which was successfully treated by chemotherapy with patient survival without recurrence for more than three years.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Podophyllotoxin; Smoking; Vincristine; Vindesine | 1987 |
Vindesine for recurrent and metastatic cancer of the uterine cervix: a phase II study.
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms; Vindesine | 1986 |